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doi:10.1Objective: Surgical ventricular reconstruction is a treatment option for patients with apical akinesia or dyski-
nesia. The Surgical Treatment for Ischemic Heart Failure trial recently demonstrated its safety but no added ben-
efit to bypass surgery, although the trial’s inclusion criteria did not contain shape or viability parameters.
However, we evaluated cardiac magnetic resonance-derived parameters as potential predictors of function after
surgical ventricular reconstruction.
Methods: In 24 patients with cardiac magnetic resonance before and after surgical ventricular reconstruction,
we assessed cardiac volumes, function, scar, and geometry (sphericity index, short to long axis; apical conicity
index, apical to short axis; apical volume index, apical to basal volume).
Results: Surgical ventricular reconstruction significantly reduced ventricular volumes (64.2%) and increased
global ejection fraction by 12% (P<.01). The sphericity index was increased by surgical ventricular reconstruc-
tion (0.60 0.07 vs. 0.76 0.13. P<.05) indicative of ball shapes. The apical to short axis (0.71 0.13 to 0.58
 0.09) and apical to basal volume (0.45  0.08 to 0.26  0.11) decreased, consistent with aneurysm removal.
The preoperative ventricles contained 25% 14% of scar (apical: 72% 8%, midcavity: 38% 14%, basal
region: 10%  12%). Patients with ejection fraction improvement greater than 12% had less basal scar preop-
eratively and showed greater apical to basal volume reduction than thosewith ejection fraction improvement less
than 12%. Basal wall motion scores did not differ between the subgroups. However, multivariable analysis
identified only ejection fraction and urgency of operation as independent risk predictors.
Conclusions: The assessment of basal viability and the determination of the apical to basal volume may allow
identifying the subgroup of patients who potentially derive a benefit from surgical ventricular reconstruction.
A larger study is needed to support this conclusion. (J Thorac Cardiovasc Surg 2011;142:1515-22)P
MSupplemental material is available online.
Cardiac magnetic resonance (CMR) is often used to assess
ventricular shape, volume, and viability before a revascular-
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The Journal of Thoracic and Carventricular reconstruction (SVR) has been an accepted
treatment option for patients with ischemic heart failure
presenting with postinfarct akinesia or dyskinesia.3 These
patients usually have large aneurysms giving the typical
dyskinetic picture of left ventricular apex, but SVR has
also been advocated for patients with dilated hearts and aki-
netic anterior walls.3 The Surgical Treatment for Ischemic
Heart Failure (STICH) trial just addressed the impact of
SVR on survival and reported that SVR was safe, but did
not add an extra survival or quality of life benefit to the
effects of bypass surgery alone.4 Although this outcome is
definitive and certainly represents a setback for the broad
application of the procedure, the trial’s inclusion criteria
for patients with anterior akinesia or dyskinesia did not in-
clude parameters determining shape, regional contractility,
or myocardial viability. Thus, the demonstration of the
safety of the procedure may therefore be used as an encour-
agement to clearly define the subgroup of this patient pop-
ulation who does derive a benefit.
To achieve this goal, new, regional parameters and the
degree of viable myocardium need to be assessed. The com-
monly used parameters to address the effectiveness of thediovascular Surgery c Volume 142, Number 6 1515
Abbreviations and Acronyms
ACI ¼ apical conicity index
AVI ¼ apical volume index
CMR ¼ cardiac magnetic resonance
EF ¼ ejection fraction
LAL ¼ long-axis length
SAL ¼ short-axis length
SpI ¼ sphericity index
STICH ¼ Surgical Treatment for Ischemic Heart
Failure
SVR ¼ surgical ventricular reconstruction
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Mprocedure have been the left ventricular ejection fraction
(EF) and left ventricular volumes, but both are changed as
a natural consequence of this volume-altering procedure.
Shape indices obtained by conventional ultrasound5 or
3-dimensional echocardiography6 have been introduced
and are tools to describe regional and global left ventricular
shape. However, the availability of echocardiographic data
pre- and post-SVR are still limited, and those of CMR are
practically absent.
We therefore analyzed all patients in our database who
obtained CMR before and after SVR and assessed myocar-
dial function, geometry, and viability pre- and post-SVR.MATERIAL AND METHODS
Patients
In this retrospective analysis, we identified 24 patients in our database
between 2002 and 2008 who underwent SVR and obtained CMR both be-
fore and after the procedure (192 patients underwent SVR in this time pe-
riod). These patients were used for the present analysis. All patients agreed
to the scientific assessment of their parameters by signing a consent form
preoperatively. The management of our database is consistent with the
qualifications set forth by the ethics committee of the University of Leipzig.
The conduct of the study is in agreement with the Declaration of Helsinki.
Conduct of Operation and Perioperative Care
The procedures were performed with the patients connected to cardio-
pulmonary bypass and their hearts arrested with cold blood cardioplegia
(n ¼ 22) or induced fibrillation (n ¼ 2). Concomitant procedures included
coronary artery bypass grafting in 18 cases (9 single, 6 double, 1 triple, and
2 quadruple bypasses), mitral valve reconstruction in 7 cases, aortic valve
replacement in 2 cases, and use of intraaortic balloon pump in 2 cases. All
procedures were performed in a similar fashion. The anterior wall was in-
cised, and the transitional zone between infarcted and viable myocardium
was visually identified. A Fontan purse-string suture was placed and tied,
and the remaining opening was closed with overlapping felt-reenforced
Prolene sutures either directly or with the use of a patch. The scar tissue
was oversewn and excluded from the cavity. The exact amount of scar
tissue or ventricle excluded from the cavity depended on the individual sur-
geon and was therefore based on personal judgment. All patients received
the same routine intra- and postoperative care. Perioperatively, all patients
received standard heart failure medication, including the administration of
angiotensin-converting enzyme inhibitors or angiotensin II receptor
blockers, beta-blockers, and diuretics.1516 The Journal of Thoracic and Cardiovascular SurCardiac Magnetic Resonance
CMR was performed on a 1.5 T scanner (Intera; Philips, Best, The
Netherlands) using an 8-element phased-array surface coil. Details of the
volumetric, functional, and viability assessment have been described.2
Determination of Cardiac Magnetic Resonance-
Derived Volumetric, Geometric, Functional, and
Viability Parameters
Left ventricular volumes. All measurements were obtained from
the horizontal long axis (4-chamber view), vertical long axis (2-chamber
view), and a contiguous set of short-axis slices. The endo- and epicardial
myocardial borders of the left ventricle were manually planimetered in
all short-axis slices with a mouse-driven cursor using the software
Extended MR Work Space (Release 2.6.1 2008; Philips Medical System,
Nederland BV, The Netherlands); afterward, the software automatically
multiplied these planimetered areas by the slice thickness. Papillary mus-
cles were included in the LV cavity. Consequently, left ventricular volumes
were summed to give the total ventricular volume at end-diastole and
end-systole according to the Simpson rule algorithm.7 The left ventricular
muscle mass was automatically generated by the software. For all volumet-
ric parameters, the left ventricular end-diastolic and systolic volume indi-
ces were calculated using the formula by Du Bois and Du Bois.8
Left ventricular global and regional function. In addition
to left ventricular ejection fraction and stroke volume, the cardiac index
(L/min $m2) was calculated as the ratio of cardiac output and body surface
area.7,9 Basal function (Figure 1, E) was determined using the following
algorithm: The mean amount of equidistant slices of this acquisition
depended on the length of the left ventricle and ranged from 9 to 12
(Figure 1, C, D). The volume for each slice was calculated from the slice
area and slice thickness. The ratio of the mean end-diastolic and mean
end-systolic volumes of the 3 most basal slices (blue markings in
Figure 1, E) was calculated and used to reflect regional basal EF. Regional
basal EF therefore describes the fractional volume change during the
cardiac cycle in the basal 3 slices.
Local wall motion was visually analyzed on the steady-state free-pre-
cession cine-magnetic resonance imaging by one experienced radiologist
using the 17-segment model of the American Heart Association.10 Seg-
ments 17 to 13 represent the apical portion, segments 12 to 7 represent
the mid-cavity, and segments 6 to 1 represent the basal portion of the ven-
tricle. For each segment, the local wall motion was classified pre- and post-
operatively using a qualitative scoring system with the following scale:
0 ¼ normokinetic, 1 ¼ hypokinetic, 2 ¼ akinetic, 3 ¼ dyskinetic.
To assess the completeness of revascularization from the bypass part of
the procedure (75% of patients received at least 1 coronary artery bypass
graft), we obtained information about the respective coronary circulation
dominance and the localization and extension of the coronary artery steno-
ses. We matched these findings to the position of the bypass grafts. This
matching allowed us to estimate with relatively high precision if a certain
segment of the 17-segment model was completely revascularized or not.
The assignment of segments to coronary artery territories was based on the
recommendations of theAmericanHeartAssociation,10 considering the lim-
itation that there is considerable variability in myocardial blood supply.
Geometric Indices
Three different geometry indices, 2 already known from echocardiogra-
phy,5 were used to describe left ventricular shape conditions pre- and post-
SVR by using patient-specific ventricular dimensions and volumes
(Figure 1, A–D). The long-axis length (LAL) was defined as the distance
from the apex to the center of the mitral valve (visualized by a reference
line imposed at the level of the mitral annulus). The short-axis length
(SAL) was defined as the distance between the interventricular septum
and the lateral wall of the left ventricle perpendicular to and at the center
of the LAL.gery c December 2011
FIGURE 1. Determination of the examined geometry and functional indices. A, SpI is determined as the ratio of the internal diameters in SAL and LAL. B,
ACI is determined as the ratio of the internal diameters in AAL and SAL. C, AVI is determined by the volume in the apical half of equidistant slices applied to
the preoperative ventricle. D, For determination of the postoperative AVI, the volume in the same number of basal slices and the volume in the remaining
apical slices are calculated and divided by each other (apical/basal). E, Regional basal EF is determined as the ratio of the mean end-diastolic and the mean
end-systolic volume of the 3 most basal slices. SAL, Short-axis length; LAL, long-axis length; AAL, apical axi length; ACI, apical conicity index; SpI,
sphericity index.
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MSphericity Index
The sphericity index (SpI) was defined as the ratio of the diameters SAL
and LAL (Figure 1, A).
Apical Conicity Index
The apical conicity index (ACI) was obtained as described byDi Donato
and colleagues.5 A sphere was fitted to the apex, and its diameter was then
divided by the SAL (Figure 1, B).
Apical Volume Index
Figure 1, C and D, illustrates how the apical volume index (AVI) was
determined. The left ventricular volumewas sectioned into short-axis slices
of equal thickness starting at the mitral valve annulus during end-diastole
and end-systole. The preoperative AVI was determined as the ratio of the
volume represented by the apical half of the slices divided by the volume
in the basal half of the slices. Postoperatively, the same slices were appliedThe Journal of Thoracic and Carto the reconstructed ventricle starting at the mitral valve annulus during
end-diastole and end-systole. The basal volume was again calculated
from the same number of basal slices. Because of the reconstruction pro-
cedure, the number of apical slices was then reduced. Because the apical
volume is likely to be reduced more than the volume in the basal sections
by the operative procedure, the ratio is expected to decrease. However, the
degree of decrease will depend on the amount of volume reduction and the
amount of reshaping of the basal part. A spherical shape is likely to leave
the basal volume unaffected, whereas the recreation of a conical shape is
likely to slim the basal part.Scar Tissue Assessment
The late gadolinium-DTPA enhancement images were analyzed, and
the hyperenhancement area was quantified by planimetry in all acquired
inversion recovery-gradient recalled echo short-axis slices using the
same software by Philips (the section ‘‘Left ventricular volumes’’).diovascular Surgery c Volume 142, Number 6 1517
TABLE 1. Demographic data of the 24 patients having undergone
surgical ventricular reconstruction and the division into subgroups










Age, y 58.7 61.7 57.1 .354
NYHA class
I 4/24 2/10 2/14 1.000
II 2/24 1/10 1/14 1.000
III 11/24 5/10 6/14 1.000
IV 7/24 2/10 5/14 1.000
Hypertension 16/24 6/10 9/14 1.000
Diabetes 9/24 5/10 4/14 .403
Pulmonary hypertension 4/24 3/10 1/14 .272
PVD 1/24 0/10 1/14 1.000
COPD 4/24 1/10 3/14 .615
Hyperlipidemia 16/24 6/10 10/14 .673
Previous PCI 7/24 2/10 5/14 .653
Prior heart operation 2/24 1/10 1/14 1.000
Preoperative MI 15/24 5/10 10/14 .403
Coronary artery diseases
1 vessel 6/24 3/10 3/14 .665
2 vessel 7/24 3/10 4/14 1.000
3 vessel 11/24 4/10 7/14 .697
P values reflect comparison of the 2 subgroups. PVD, Peripheral vascular disease;
COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association;
MI, myocardial infarction; PCI, percutaneous coronary intervention.
TABLE 2. Operative parameters of the 24 patients and the division











Elective 14/24 8/10 6/14 .104
Urgent 8/24 2/10 6/14 .388
Emergency 2/24 0/10 2/14 .493
CABG 18/24 7/10 11/14 .665
None 6/24 3/10 3/14 .665
Single 9/24 4/10 5/14 1.000
Double 6/24 2/10 4/14 1.000
Triple 1/24 0/10 1/14 1.000
Quadruple 2/24 1/10 1/14 1.000
Concomitant MVR 7/24 5/10 2/14 .085
Duration of operation (min) 200 206 195 .642
CPB (min) 103 109 98 .513
Aortic crossclamp time (min) 58 57 58 .933
Preoperative inotrope requirements
None 20/24 8/10 12/14 1.000
Low-dose 4/24 2/10 2/14 1.000
High-dose 0/24 0/10 0/10
Postoperative inotrope requirements
None 11/24 4/10 7/14 .697
Low-dose 11/24 6/10 5/14 .408
High-dose 2/24 0/10 2/14 .493
IABP 2/24 0/10 2/14 1.000
P values reflect comparison of the 2 subgroups.CPB,Cardiopulmonary bypass; IABP,
intraaortic balloon pump; MVR, mitral valve reconstruction; CABG, coronary artery
bypass graft.
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MHyperenhancement was defined as scar tissue with a signal intensity of at
least 2 standard deviations above the mean signal intensity of viable remote
myocardium,2,11 in accordance with the typical morphologic aspect of
infarcted myocardium. Finally, the planimetered scar areas were
multiplied by the slice thickness and the total scar-mass was obtained
and put into relation to the total myocardial mass. In addition, for each seg-
ment of the 17-segment model the local extension of the myocardial scar
tissue was classified as transmural (at least 75% of the wall), intermediate
(50%), subendocardial (<25%), or no infarction (0%).
Statistical Analysis
Data are presented as mean  standard error of the mean. The 24 pa-
tients were subdivided into 2 groups according to their functional recovery
(1 group with above average recovery of function and 1 group with below
average recovery of function) to find predictors of functional outcome (see
‘‘Results’’). Statistical analysis was performed using SPSS software 15.0
for windows, version 15.0.1 (SPSS Inc, Chicago, Ill). A paired, 2-tailed
Student t test, chi-square test, and Kaplan–Meier survival curve were
used. We also performed a multivariate analysis to identify independent
prognostic preoperative factors.RESULTS
Demographics
Table 1 shows the demographic data of all patients. Pa-
tients were aged an average of 59 years and mainly in
NewYork Heart Association class III or IVat the time of op-
eration. The decision to perform SVR in our patients was
mainly based on the presence of an apical aneurysm after
myocardial infarction. As will be described below in further
detail, ejection fraction improved on average by 12%1518 The Journal of Thoracic and Cardiovascular Surthrough the surgical procedure. By aiming to identify those
patients who benefited most from the procedure, we divided
the 24 patients into 2 groups: those with greater than 12%
improvement in EF and those with less than 12% improve-
ment in EF (Table 1). There were no significant demo-
graphic differences between the 2 groups.
Operative Characteristics
Table 2 shows the operative parameters of the patients.
The majority of patients underwent the procedure elec-
tively. Two patients received an intraaortic balloon pump.
Both of them were in the subgroup with poor improvement
of function. The majority of patients also received bypass
grafting, and one quarter of patients obtained a mitral valve
repair for moderate to severe mitral regurgitation. Also,
there were no statistically significant differences in the
operative characteristics between the 2 subgroups.
The average degree of mitral regurgitation of patients
who did not receive mitral valve reconstruction was grade
0.47  0.51 before surgery and grade 0.41  0.51 after
surgery (P¼ .668). Four patients improved, 2 patients wors-
ened by 1 degree without the need for reintervention, and 15
patients remained the same. All reconstructed valves had
more than mild mitral regurgitation before surgery and
were competent at the end of the procedures (n ¼ 7). Newgery c December 2011
TABLE 3. Cardiac magnetic resonance-derived parameters of the 24
patients before and after surgical ventricular reconstruction
Parameters Pre Post P value
LVEF (%) 25  1.64 37  2.28 <.001
LVEDVI (mL/m2) 148  10.8 95  8.77 <.001
LVESVI (mL/m2) 114  10.9 64  8.68 <.001
LV-MM (mL) 180  12.8 142  9.13 <.001
CI (L/min $ m2) 2.49  0.13 2.48  0.13 .961
Apical motion 2.80  0.07 2.44  0.13 .007
Basal motion 0.76  0.08 0.56  0.08 .001
RBEF (%) 52.9  3.41 54.5  3.30 .530
SpI (4CH-dia) 0.60  0.01 0.76  0.03 <.001
ACI (4CH-dia) 0.71  0.03 0.58  0.02 <.001
AVI
Diastole 0.45  0.02 0.26  0.02 <.001
Systole 0.54  0.02 0.32  0.03 <.001
Total scar (mL) 42.98  5.56 n.a.
Total scar (%) 24.56  2.88 n.a.
Apical scar (%) 71.67  1.58 n.a.
Mid-cavity scar (%) 37.29  3.22 n.a.
Basal scar (%) 10  2.53 n.a.
Basal and apical motion scale: 3 ¼ dyskinesia, 2 ¼ akinesia, 1 ¼ hypokinesia,
0 ¼ normokinesia. LVEF, Left ventricular ejection fraction; LVEDVI, left ventricular
end-diastolic volume index; LVESVI, left ventricular end-systolic volume index;
LV-MM, left ventricularmusclemass;CI, cardiac index;RBEF, regional basal ejection
fraction.
FIGURE 2. EF (%) of all patients before and after SVR and their individ-
ual direction of change.
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MYork Heart Association functional class improved in all pa-
tients on average from 2.9  1.0 to 2.1  1.2 (P ¼ .009).
Cardiac Magnetic Resonance Assessment of
Function, Volumes, and Geometry
Table 3 shows the CMR data of the patients before and
after SVR. Consistent with other reports,4,12 our study
found a significant reduction in left ventricular volumes
associated with the already mentioned improvement in
ejection fraction by 12%. The SpI was increased by SVR,
indicating the creation of ball shapes by the procedure.
The ACI and AVI decreased, which is consistent with
aneurysm removal. The preoperative ventricular muscle
mass consisted to one quarter of the scar. Its relative
proportion was greatest in the apical and lowest in the
basal region.
Figure 2 illustrates the change of left ventricular ejec-
tion fraction of all patients. The average increase was
12%. On the basis of these outcomes, we divided the
group into 2 subgroups described above. Table 4 shows
the CMR-derived parameters for the 2 subgroups. There
was no difference in volume reductions, global amount
of scar, or sphericity or apical conicity indices determined.
There was also no difference in the regional basal EF, in-
dicating that the degree of basal wall motion may not be
predictive for postoperative function. Table E1 shows the
local scar tissue distribution according to the American
Heart Association 17-segment model, which was used asThe Journal of Thoracic and Carthe basis for our apical, mid-cavity, and basal region as-
sessment (see ‘‘Materials and Methods’’ for details). The
scar tissue distribution was mostly transmural in the api-
cal, intermediate in the mid-cavity, and subendocardial
in the basal region. There was no difference between the
2 subgroups in the apical and mid-cavity region. Because
of this finding, we postulated that differences in the out-
come of this homogenous cohort should be reflected in
the basal scar distribution, because the residual contractil-
ity of the ventricle is generated in this area and should be
affected by scar tissue.
Figure 3, A, illustrates the fractional scar tissue in the
basal myocardium. Patients with poor improvement of post-
operative EF had more basal scar than those with large EF
improvement. Figure 3, B, shows the newly introduced
apical volume index. Patients with large EF improvements
had smaller AVI after SVR than those with lower improve-
ments, indicating that greater volume reductions during
surgery are associated with better functional outcome.
Table E2 shows the local wall motion analysis on the ba-
sis of the 17-segment model of the American Heart Associ-
ation and on our qualitative scoring system. The scoring
system indicated significant improvements in function in
the mid-cavity and basal regions. On the basis of our assess-
ment of complete revascularization (see ‘‘Materials and
Methods’’ for details), we distinguished segments that
were revascularized from those that were not revascular-
ized. According to this approximation, only 22% of all im-
provements of regional function were located in segments
that have received revascularization and 77% of all regional
functional improvements were located in non-revascularized
segments. Functional improvements in the basal regions
were associated with the greatest lack of revascularization
(86%), indicating that the functional improvement may
be more influenced by the SVR procedure than by
revascularization.diovascular Surgery c Volume 142, Number 6 1519




Preoperative Postoperative Preoperative Postoperative
LVEF 24  2.17 44  2.80* 26  2.39 31  2.50*
LVEDVI (mL/m2) 146  14.7 81  10.2* 150  15.7 106  12.7*
LVESVI (mL/m2) 113  13.2 47  8.41* 115  16.7 77  12.9*
RBEF (%) 54  4.88 58  4.48* 53  4.85 52  4.70*
Basal wall motion 0.70  0.13 0.45  0.11 0.80  0.11 0.64  0.10*
SpI 0.57  0.02 0.77  0.05 0.61  0.02 0.75  0.03
ACI 0.71  0.05 0.56  0.04* 0.71  0.03 0.60  0.02
Total scar (mL) 41  10.4 n.a. 44  6.29 n.a.
Total scar (%) 21  5 n.a. 26  4 n.a.
Apical scar (%) 74  1 n.a. 70  3 n.a.
Mid-cavity scar (%) 39  5 n.a. 38  4 n.a.
Basal scar (%) 03  2 n.a. 15  4y n.a.
Basal wall motion scale: 3¼ dyskinesia, 2¼ akinesia, 1¼ hypokinesia, 0¼ normokinesia. LVEF, Left ventricular ejection fraction; LVEDVI, left ventricular end-diastolic volume
index; LVESVI, left ventricular end-systolic volume index; RBEF, regional basal ejection fraction. *P<.05 versus preoperative. yP<.05 vs DEF>12%.
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MMidterm Survival
Figure 4 shows a Kaplan–Meier survival curve for the 2
subgroups. In our cohort, the mean survival time was 66
months. In this time, 2 patients (8.3%) died 3 and 13
months after surgery. Both showed preoperatively a high
amount of myocardial scar (27.6% and 46.7%). Of note,
both had a below average improvement in ejection fraction
postoperatively (4.3% and 8.3%).
DISCUSSION
We demonstrated in this analysis that the assessment of
regional scar content, especially in the basal region of the
heart may help to determine a subgroup of patients who po-
tentially benefits from surgical ventricular reconstruction
(SVR). We also showed that the previously described geo-
metric indices and shape beliefs are not associated with
an improvement in postoperative function. Finally, we
showed that the degree of volume reducing reflected in
the newly introduced apical volume index (AVI) pre and
post-surgery appeared to have a global functional impact.
However, multivariate analysis failed to identify the above
mentioned parameters as independent prognostic factors.
These findings need further discussion.
Although the study is to date the largest one presenting
pre- and postoperative CMR in patients having received
SVR, the total number of 24 patients is too small to expect
a multivariate analysis to deliver final results. We therefore
arrived at our conclusions with the understanding that our
results are hypothesis generating. However, they are cur-
rently of great interest because of the overall negative re-
sults of the SVR hypothesis of the STICH trial.4 This trial
demonstrated no added benefit of SVR to conventional by-
pass surgery alone. However, because of the lack of specific
inclusion criteria for SVR, the trial’s patient population hav-
ing received SVR is heterogeneous and contains patients1520 The Journal of Thoracic and Cardiovascular Surwith dilated hearts and mainly akinetic anterior walls, and
patients with clearly defined apical aneurysms of different
sizes and often adequately maintained contractility in the
remaining ventricle. Therefore, there should be a subgroup
(those with an improvement of left ventricular function
above the mean) that benefits from the procedure. However,
it is important to realize in this context that for every patient
who benefits, the entire cohort contains a counterpart who
takes harm. Therefore, identifying preoperative determi-
nants of outcome is extremely important.
Intuitively, onewould assume that function in the remain-
ing myocardiummight be a predictor of outcome. However,
our data indicate that mid-cavity and basal contractility do
not correlate with postoperative global function. A most
recent report from the STICH trial supports this finding
by being unable to identify subgroups of patients receiving
benefit or harm from SVR based on regional contractility.13
However, regional scar content in the basal part of the left
ventricle was inversely correlated with postoperative func-
tion in our analysis. These results are consistent with those
of Takeda and colleagues,14 who assessed regional scar
content in a smaller series than ours and did not assess
global scar content and the geometric indices. Nevertheless,
the evidence for basal scar content to be a preoperative
predictor of outcome is growing,14,15 and larger studies
are required to assess its true prognostic impact. This
discrepancy between basal contractility and basal scar
content as a predictor of functional outcome reflects the
methodical superiority of late gadolinium-DTPA enhance-
ment to a qualitative scoring system of wall motion only.
The advantage of late gadolinium-DTPA enhancement
may be that it objectively assesses irreversible myocardial
damage, whereas wall motion changes may vary signifi-
cantly and are influenced by dynamic factors (eg, volume
load).16gery c December 2011
FIGURE 3. A, Fractional scar content of myocardial scar tissue in the api-
cal, mid-cavity, and basal regions illustrated for the subgroups of patients
with DEF<12% (open bars) and DEF>12% (filled bars). B, AVI before
and after SVR in the subgroups of patients with DEF<12% (open bars)
and DEF>12% (filled bars) showing the significant difference between
the groups. A, B, Note the significantly smaller amount of basal scar and
the significantly greater reduction in AVI in patients with better functional
improvement. AVI, Apical volume index; EF, ejection fraction.
FIGURE 4. Kaplan–Meier survival curve for the 2 examined subgroups
(DEF<12% red line and DEF>12% black line). EF, Ejection fraction.
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MAnother issue that has raised heated debates is the shape
of the pre- and postoperative ventricle. Buckberg and col-
leagues17 and Menicanti and Di Donato18 reported that
the creation of a cone-shaped ventricle is important, and
specific modifications in the conduct of this procedure aim-
ing at that shape have been described.19,20 However, there is
currently no evidence that a difference in shape affects
outcome. To the contrary, the surgeon reporting the best
result in this group of patients (V. Dor) has the highest
propensity to create ball-shaped ventricles (because of his
volume assessment with a ball-shaped device and implanta-
tion of mainly round patches).21 Our analysis of the recently
introduced geometric indices addressing shape (signal in-
tensity, ACI) supports this notion. There seems to be no re-
lationship between the change in shape according to the SpI
and ACI and the degree in functional improvement afterThe Journal of Thoracic and Carsurgery. Although it seems from our data that ball shapes
do not eliminate the possibility of significant functional im-
provement, we cannot make any statement about the impact
of conical shapes because most of our patients had more
ball-type shapes. However, because of the good functional
improvements and the tendency to spherical ventricular
shapes post-SVR in our cohort, we conclude that spherical
shape is at least not absolutely contradicting good func-
tional outcome.
We introduced a new volume index with this study. The
preoperative AVI is determined as the ratio of the volume
represented by the apical half divided by the volume of
the basal half of the ventricle. They have been determined
by sectioning the ventricle in equidistant slices and deter-
mining a basal set of slices and an apical set of slices. Be-
cause of the apical localization of the procedure, the
apical set of slices was reduced and not the basal set of sli-
ces. Thus, the significant reduction of the volume indices
postoperatively was expected. However, the statistically
larger AVI reduction in patients with good EF improvement
was not predictable. One may argue that more aggressive
volume reduction may result in better functional outcome.
However, regional contractility was not different between
the 2 groups, and global EF is a function of ventricular vol-
umes. Thus, the association of smaller volumes with larger
global postoperative ejection fractions seems to be a mathe-
matic rather than a functional effect. In addition to this func-
tional considerations, it is always difficult to distinguish the
effects of the SVR procedure from the effects of revascular-
ization. Despite this limitation, we do provide evidence in
this article that SVR seems to have an effect on contractile
function. This conclusion is based on our matching of re-
gional contractility to the presence or the lack of concomi-
tant revascularization in the 17 segments. Because most of
the segments experienced functional improvement but only
one fifth received revascularization through bypass grafting,diovascular Surgery c Volume 142, Number 6 1521
Perioperative Management H€uther et al
P
Mit is reasonable to conclude that SVR has a functional im-
pact independent of revascularization.
The above reasoning on the interplay of volume, volume
reduction, and ejection fraction also reflects the greatest
limitation in this study (ie, the limited number of patients
as already eluded to before). Because of this small number,
we were not able to assess the impact of the procedure on
clinical outcome independently of function. Thus, the ques-
tion whether the differences in functional outcomewill help
to identify the expected subgroup of patients deriving a sur-
vival benefit cannot be fully answered. Our survival curve
may serve as a small and indirect token of support for this
connection (both patients who died were in the group
with poor functional recovery), but certainly not as proof.
Despite these limitations, our analysis is still the largest cur-
rently available one, and the evidence we provide strongly
suggests that the assessment of regional parameters (specif-
ically basal scar content and the newly introduced apical
volume index) deserve further assessment in larger trials
with preoperative primary outcome parameters.
CONCLUSIONS
The assessment of regional scar content may help to de-
termine a subgroup of patients who benefit from surgical
ventricular reconstruction. The previously described geo-
metric indices and shape beliefs are not associated with im-
provement in postoperative function. Because these
conclusions are not backed by the results of the multivariate
analysis, there is a great need for a larger study to support
these results.
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TABLE E1. Fractional content of scar tissue in percentage of patients’ left ventricles before surgical ventricular reconstruction according to 17-
segment model (American Heart Association)
Myocardial region All patients DEF>12% DEF<12% P value
Total scar (%) 25  3 15  5 14  4 .338
Regional scar (%)
Apical
Apex (17) 0.75  0.00 0.75  0.00 0.75  0.00 1.000
Lateral (16) 0.69  0.03 0.73  0.03 0.66  0.06 .310
Inferior (15) 0.69  0.04 0.73  0.03 0.66  0.06 .350
Septal (14) 0.72  0.02 0.75  0.00 0.70  0.03 .128
Anterior (13) 0.73  0.01 0.75  0.00 0.73  0.02 .410
Mid-cavity
Anterolateral (12) 0.28  0.07 0.28  0.11 0.28  0.08 .960
Inferolateral (11) 0.25  0.06 0.23  0.10 0.27  0.07 .735
Inferior (10) 0.24  0.06 0.33  0.11 0.18  0.05 .198
Inferoseptal (9) 0.38  0.06 0.45  0.10 0.36  0.09 .482
Anteroseptal (8) 0.55  0.04 0.53  0.10 0.61  0.04 .413
Anterior (7) 0.54  0.05 0.53  0.10 0.59  0.04 .523
Basal
Anterolateral (6) 0.05  0.04 0.00  0.00 0.10  0.06 .240
Inferolateral (5) 0.03  0.03 0.00  0.00 0.10  0.10 .336
Inferior (4) 0.03  0.02 0.00  0.00 0.10  0.03 .128
Inferoseptal (3) 0.01  0.04 0.03  0.03 0.16  0.07 .140
Anteroseptal (2) 0.23  0.06 0.10  0.06 0.34  0.10 .059
Anterior (1) 0.14  0.05 0.03  0.03 0.23  0.08 .047
Transmural>0.75, intermediate 0.5, subendocardial<0.25, no infarction 0.
TABLE E2. Local wall motion assessed by cardiac magnetic resonance pre- and post- surgical ventricular reconstruction of all 24 patients
according to the American Heart Association 17-segment model
Myocardial region Preoperative Postoperative P value
Apical
Apex (17) 2.9  0.06 2.75  0.11 .103
Lateral (16) 2.75  0.11 2.38  0.17 .026
Inferior (15) 2.75  0.10 2.21  0.17 .002
Septal (14) 2.79  0.09 2.33  0.18 .008
Anterior (13) 2.79  0.09 2.54  0.13 .031
Mid-cavity
Anterolateral (12) 1.33  0.13 0.63  0.15 <.001
Inferolateral (11) 1.66  0.13 1.13  0.15 <.001
Inferior (10) 1.5  0.13 1.00  0.14 .001
Inferoseptal (9) 1.5  0.10 1.13  0.10 <.001
Anteroseptal (8) 1.5  0.10 1.0  0.10 <.001
Anterior (7) 1.33  0.16 0.79  0.13 .001
Basal
Anterolateral (6) 0.33  0.10 0.25  0.09 .162
Inferolateral (5) 0.33  0.10 0.25  0.09 .162
Inferior (4) 0.83  0.13 0.63  0.12 .022
Inferoseptal (3) 1.04  0.14 0.79  0.12 .011
Anteroseptal (2) 1.13  0.13 0.83  0.12 .005
Anterior (1) 0.92  0.12 0.63  0.12 .005
Wall motion scale: 3 ¼ dyskinesia, 2 ¼ akinesia, 1 ¼ hypokinesia, 0 ¼ normokinesia.
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